Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Onconephrology
•
Hospital Medicine
How do you manage Fanconi’s syndrome and polyuria related to ifosfamide?
Related Questions
What are your management strategies for acute kidney injury attributed to pembrolizumab in patients with a kidney biopsy showing predominately acute tubular injury?
Would you recommend administering IV amino acids prior to cardiac surgery with cardiopulmonary bypass, given recent trial findings of improved AKI rates but no significant difference in kidney-replacement therapy with IV amino acids?
Do you perform a kidney ultrasound in patients following a kidney biopsy to evaluate for post-procedural complications?
Do you prefer assessing cystatin C or creatinine when monitoring a patient’s eGFR who is receiving chemotherapy for malignancy?
Do you recommend plasmapheresis for treatment of patients with osmotic demyelination?
Are there instances when you recommend initiation of hemodialysis for patients with severe symptomatic hypercalcemia?
Do you start patients on a B complex multivitamin if they are on CRRT and have not previous been on renal replacement therapy?
In which clinical scenarios do you use prolonged intermittent renal replacement therapy (PIRRT)?
Do you preferentially avoid use of piperacillin-tazobactam for empiric anti-pseudomonal coverage in hospitalized patients due to risk of nephrotoxicity?
What is your approach to anticoagulation in a patient with AKI and cirrhosis who has frequent filter clotting on CRRT?
